Skip to main content
. 2010 Jun;5(6):1091–1098. doi: 10.2215/CJN.00360110

Table 2.

Characteristics of ADPKD patients and of age- and gender-matched healthy controls (live kidney donors) per quartile of agea

Variable Quartile 1
Quartile2
Quartile 3
Quartile 4
P for Trendc
ADPKD HC ADPKD HC ADPKD HC ADPKD HC ADPKD HC
Age (years) 27 ± 5 28 ± 5 35 ± 2 36 ± 2 43 ± 3 43 ± 3 54 ± 5 54 ± 5 <0.001 <0.001
Male gender, n (%) 16 (64) 16 (64) 16 (55) 16 (55) 12 (46) 12 (46) 16 (62) 16 (62) 0.6 0.6
BMI (kg/m2) 25.1 ± 4.7 25.2 ± 3.3 26.4 ± 5.2 25.4 ± 4.0 25.1 ± 3.3 24.8 ± 3.4 27.4 ± 4.6 26.9 ± 4.3 0.2 0.66
MAP (mmHg) 96 ± 11 91 ± 12 96 ± 7b 89 ± 6 96 ± 11 91 ± 7 97 ± 9 95 ± 10 0.9 0.2
Antihypertensive medicine, n (%) 15 (60)b 1 (4) 23 (79)b 0 (0) 19 (73)b 0 (0) 24 (92)b 1 (4) 0.05 1.0
ACEI/ARB, n (%) 14 (56)b 0 (0) 19 (73)b 0 (0) 18 (69)b 0 (0) 21 (81)b 0 (0) 0.3 1.0
TRV (L) 1.0 (0.7 to 2.0) 1.6 (1.1 to 2.5) 1.6 (1.1 to 2.1) 1.6 (1.1 to 2.2) 0.1
Hb (mmol/L) 8.5 ± 0.7b 9.0 ± 0.8 8.3 ± 0.8b 9.0 ± 1.0 8.3 ± 0.8 8.7 ± 0.9 8.4 ± 1.0b 8.9 ± 0.8 0.9 0.04
Serum creatinine (μmol/L) 93 ± 46b 73 ± 11 102 ± 56b 74 ± 10 107 ± 63b 71 ± 11 145 ± 92b 78 ± 13 0.04 0.2
GFR (ml/min) 117 ± 32 129 ± 17 102 ± 30b 130 ± 16 84 ± 32b 122 ± 24 74 ± 47b 116 ± 18 <0.001 0.04
ERPF (ml/min) 374 ± 119b 527 ± 83 335 ± 103b 491 ± 68 287 ± 116b 454 ± 88 203 ± 104b 429 ± 62 <0.001 <0.001
FF 32 ± 4b 25 ± 2 31 ± 4b 26 ± 3 29 ± 4b 27 ± 4 30 ± 4b 27 ± 2 0.1 0.007
RVR (dynes/cm−2) 12 (10 to 16)b 8 (7 to 9) 14 (11 to 17)b 8 (7 to 9) 17 (13 to 21)b 10 (8 to 12) 22 (18 to 33)b 10 (9 to 11) <0.001 <0.001

HC, healthy control.

a

Parametric variables are expressed as mean ± SD, whereas nonparametric variables are given as median (25th to 75th percentile).

b

P < 0.05 between ADPKD and healthy controls.

c

P values obtained using ANOVA/Kruskal–Wallis.